Allosteric Antipsychotics: M4 Muscarinic Potentiators as Novel Treatments for Schizophrenia

被引：20

作者：

Farrell, Martilias ^{[1
]}

Roth, Bryan L. ^{[1
]}

机构：

[1] Univ N Carolina, Sch Med, Dept Pharmacol, NIMH Psychoact Drug Screening Program,Div Med Che, Chapel Hill, NC 27759 USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2010年 / 35卷 / 04期

关键词：

RECEPTOR AGONIST; DRUGS; MICE; XANOMELINE; SITES;

D O I：

10.1038/npp.2009.206

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：851 / 852

页数：2

共 11 条

[1] Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease [J].

Bodick, NC ;

Offen, WW ;

Levey, AI ;

Cutler, NR ;

Gauthier, SG ;

Satlin, A ;

Shannon, HE ;

Tollefson, GD ;

Rasmussen, K ;

Bymaster, FP ;

Hurley, DJ ;

Potter, WZ ;

Paul, SM .

ARCHIVES OF NEUROLOGY, 1997, 54 (04) :465-473

[2] Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia [J].

Chan, W. Y. ;

McKinzie, D. L. ;

Bose, S. ;

Mitchell, S. N. ;

Witkin, J. M. ;

Thompson, R. C. ;

Christopoulos, A. ;

Lazareno, S. ;

Birdsall, N. J. M. ;

Bymaster, F. P. ;

Felder, C. C. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (31) :10978-10983

[3] Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery [J].

Christopoulos, A .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (03) :198-210

[4] The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs:: is M1 agonism a pre-requisite for mimicking clozapine's actions? [J].

Davies, MA ;

Compton-Toth, BA ;

Hufeisen, SJ ;

Meltzer, HY ;

Roth, BL .

PSYCHOPHARMACOLOGY, 2005, 178 (04) :451-460

[5] Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice [J].

Gerber, DJ ;

Sotnikova, TD ;

Gainetdinov, RR ;

Huang, SY ;

Caron, MG ;

Tonegawa, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :15312-15317

[6] Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice [J].

Gomeza, J ;

Zhang, L ;

Kostenis, E ;

Felder, C ;

Bymaster, F ;

Brodkin, J ;

Shannon, H ;

Xia, B ;

Deng, CX ;

Wess, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :10483-10488

[7] Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties [J].

Leach, Katie ;

Loiacono, Richard E. ;

Felder, Christian C. ;

McKinzie, David L. ;

Mogg, Adrian ;

Shaw, David B. ;

Sexton, Patrick M. ;

Christopoulos, Arthur .

NEUROPSYCHOPHARMACOLOGY, 2010, 35 (04) :855-869

[8] Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia [J].

Roth, BL ;

Sheffler, DJ ;

Kroeze, WK .

NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :353-359

[9] THE EFFECTS OF DIISOPROPYLFLUOROPHOSPHONATE IN SCHIZOPHRENIA AND MANIC DEPRESSIVE PSYCHOSIS [J].

ROWNTREE, DW ;

NEVIN, S ;

WILSON, A .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1950, 13 (01) :47-62

[10] Xanomeline, an M1/M4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice [J].

Shannon, HE ;

Rasmussen, K ;

Bymaster, FP ;

Hart, JC ;

Peters, SC ;

Swedberg, MDB ;

Jeppesen, L ;

Sheardown, MJ ;

Sauerberg, P ;

Fink-Jensen, A .

SCHIZOPHRENIA RESEARCH, 2000, 42 (03) :249-259

← 1 2 →